Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy
about
Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy
description
article
@en
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Pembrolizumab for the treatmen ...... sed review of place in therapy
@en
Pembrolizumab for the treatmen ...... sed review of place in therapy
@nl
type
label
Pembrolizumab for the treatmen ...... sed review of place in therapy
@en
Pembrolizumab for the treatmen ...... sed review of place in therapy
@nl
prefLabel
Pembrolizumab for the treatmen ...... sed review of place in therapy
@en
Pembrolizumab for the treatmen ...... sed review of place in therapy
@nl
P2093
P2860
P356
P1476
Pembrolizumab for the treatmen ...... sed review of place in therapy
@en
P2093
Anand Shah
Khaldoun Almhanna
Rutika Mehta
P2860
P304
P356
10.2147/OTT.S152513
P407
P577
2018-01-01T00:00:00Z